What Is Chemsex?

Chemsex is a specific term for sexual activity combined with particular drugs - most commonly crystal methamphetamine, GHB or GBL, and mephedrone. The term originated in the UK gay community and has been adopted internationally in both clinical and community contexts. It's distinct from sex that happens to involve recreational drug use because chemsex specifically uses drugs to extend session duration, lower inhibitions, and intensify sensation in ways those particular substances enable. The drug combination isn't arbitrary. Meth provides sustained energy and hyperarousal for extended sessions, sometimes lasting days. GHB/GBL produces a specific disinhibiting effect at low doses and loss of consciousness at higher ones. Mephedrone combines stimulant properties with empathogenic effects. Together they create a drug profile that enables the distinct behavior patterns that define chemsex sessions. Public health organizations, particularly in the UK and Europe, have addressed chemsex seriously because the combination creates specific health risks beyond general recreational drug use. GHB has an extremely narrow dose-response curve - the difference between recreational dose and dangerous overdose is small, and dangerously easy to miscalculate during sessions. Meth use is associated with addiction patterns that develop faster than many users expect. Injection drug use, which occurs in some chemsex contexts (slamming), adds HIV and hepatitis transmission risks. The sexual behavior during chemsex carries additional considerations. Longer sessions and disinhibition can lead to less careful condom use, multiple partners in rapid succession, and difficulty assessing consent both given and received. STI rates in chemsex-active populations are meaningfully higher than in general sexually active populations in the same demographics. Harm reduction approaches rather than abstinence-only messaging have become standard in most public health responses. Testing harm reduction materials, GHB dose-measuring advice, naloxone availability, and PrEP integration with chemsex support have all been documented to reduce serious outcomes. Support services specifically for people wanting to reduce or stop chemsex use exist in many urban areas with significant scenes - treatment frameworks that understand the specific drug combinations and sexual contexts perform better than generic substance-use services.